Early research (Phase 1)Ended earlyNCT01558687What this trial is testingCilengitide Imaging Trial in GlioblastomaWho this might be right forSupratentorial Newly Diagnosed Inoperable Gliobastoma Merck KGaA, Darmstadt, Germany 1